1 results match your criteria: "Center of Excellence of Type 2 Inflammation[Affiliation]"
Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment.
J Pers Med
October 2022
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center of Excellence of Type 2 Inflammation, 20122 Milan, Italy.
Article Synopsis
- Chronic rhinosinusitis with nasal polyps (CRSwNP) is a prevalent condition negatively affecting patients' quality of life and presenting significant economic challenges.
- A new treatment using subcutaneous monoclonal antibodies, particularly dupilumab, targets the inflammatory processes of CRSwNP and has shown positive results in managing severe cases resistant to standard therapies.
- The study details the organization of outpatient care, demonstrating high patient adherence to dupilumab treatment, significant improvements in symptoms, and the potential for more standardized care approaches in the medical community.